Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder

Summary

The purpose of this study is to identify evidence-based guidelines for treating major depressive disorder to full remission in Taiwanese major depressive disorder (MDD) patients. To achieve this goal, the investigators aim to: (1) evaluate the risks and benefits of adjunctive pharmacotherapies for cognitive and metabolic consequences in MDD, and (2) clarify the shared biological mechanisms between mood, immune and metabolism homeostasis

Timeline

Start

2012-08

Primary completion

2015-07

Completion

2015-07

Drugs

Indications